Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Spero Therapeutics Inc (NQ: SPRO )

1.210 -0.010 (-0.82%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 258,430
Open 1.250
Bid (Size) 1.200 (19)
Ask (Size) 1.270 (4)
Prev. Close 1.220
Today's Range 1.190 - 1.250
52wk Range 1.190 - 3.180
Shares Outstanding 52,571,813
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
4 Analysts Have This to Say About Spero Therapeutics
Via Benzinga

Performance

YTD
-30.46%
-30.46%
1 Month
-8.33%
-8.33%
3 Month
-24.38%
-24.38%
6 Month
-15.38%
-15.38%
1 Year
-45.00%
-45.00%

More News

Read More
HC Wainwright & Co. Maintains Buy Rating for Spero Therapeutics: Here's What You Need To Know
Via Benzinga
Recap: Spero Therapeutics Q1 Earnings
Via Benzinga
Spero Therapeutics's Earnings Outlook
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Spero Therapeutics's Earnings: A Preview
Via Benzinga
Earnings Outlook For Spero Therapeutics
Via Benzinga
Earnings Scheduled For August 10, 2023
Via Benzinga
Spero Therapeutics's Earnings: A Preview
Via Benzinga
Earnings Scheduled For May 11, 2023
Via Benzinga
Earnings Scheduled For March 30, 2023
Via Benzinga
Earnings Scheduled For November 14, 2022
Via Benzinga
Earnings Outlook For Spero Therapeutics
Via Benzinga
How Is The Market Feeling About Spero Therapeutics?
Via Benzinga
EXCLUSIVE: Top 10 Stocks Searched On Benzinga Pro In September: Where Do Tesla, Apple, Bed Bath & Beyond Rank?
Via Benzinga
This Analyst Slashes PT On Lyft By 68%, Plus Telsey Advisory Group Predicts $125 For Nike
Via Benzinga
Short Volatility Alert: Spero Therapeutics, Inc.
Via Benzinga
Spero Therapeutics To Rally Around 240%? Plus This Analyst Slashes PT On Salesforce
Via Benzinga
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
Via Benzinga
Dow Turns Higher; Crude Oil Rises 0.7%
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Stocks Keep Sinking As Wall Street Comes To Terms With Fed Hike
Via Talk Markets
Spero Therapeutics (NASDAQ: SPRO) Enters into Exclusive Licensing Agreement with GSK (NYSE: GSK) for the Commercialization of Tebipenem HBr
Via Spotlight Growth
Exposures Product Safety
Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.